The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef

Podcast

biobytes: May 4, 2009

The Rockefeller University Press

biobytes{at}rockefeller.edu

In the May 4th edition of biobytes we hear from Tatiana Petrova (University of Lausanne, Switzerland) about lymph vessel development (Norrmén et al., JCB), Makkuni Jayaram (University of Texas, Austin, TX) talks parasite persistence (Cui et al., JCB), and Thomas Jung (Novartis, Basel, Switzerland) tells us about a new drug to combat the autoinflammatory syndrome, CAPS (Lachmann et al., JEM; Nakamura et al., JEM). The show was written, presented and produced by Ruth Williams, with additional reporting by Justin Paul.

01:00 - Lymph vessel development; 05:10 - Parasite persistence; 10:30 - Canakinumab, a new drug for CAPS.

biobytes
Listen now

Subscribe to biobytes via iTunes or RSS
View biobytes archive





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef


  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS